RML to appliy Abbott's latest diagnostics technology

Abbott recently announced that Regional Medical Laboratory, Inc. (RML) will use the company's most advanced technology, Alinity ci-series, to conduct diagnostic testing for millions of patients. RML, part of the Ascension network, which is the largest non-profit health system in the U.S., performs diagnostics testing for more than 2.4 million patients through hospital systems.

Diagnostic testing plays an important role in many aspects of healthcare, guiding 70 percent of critical clinical decisions. Alinity's innovative design provides fast, accurate testing in a smaller footprint that can improve diagnostic testing and increase the potential for RML to impact healthcare. The installation of Alinity in RML facilities will include a custom automation line, which will eliminate many manual procedures, freeing up time for the lab to focus on activity that supports patient care. 

RML consistently experiences a 3 to 5 percent increase in test volumes year on year. The scalable design of the Alinity ci-series will make it easier for RML to add additional instruments as their volume continues to rise.

Register as Visitor to CPhI China 2019!

-----------------------------------------------------------------------
Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.